Remission of hypertension and electrolyte abnormalities following renal transplantation in a patient with apparent mineralocorticoid excess well documented throughout childhood

Journal of Pediatric Endocrinology and Metabolism

Volumn 27, Issue 1-2, 2014, Pages 17-21

  Khattab, Ahmed M ^a   Shackleton, Cedric H L ^b   Hughes, Beverly A ^b   Bodalia, Jayesh B ^c   New, Maria I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c MEMORIAL HEALTH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

11 HSD2; AME; Cortisol; Mineralocorticoid

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 2; ALDOSTERONE; ARGININE; BICARBONATE; CREATININE; DEXAMETHASONE; HISTIDINE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; HYDROCORTISONE; NUCLEOTIDE; POTASSIUM; RENIN; SPIRONOLACTONE; ELECTROLYTE;

ADULT; ALDOSTERONE URINE LEVEL; ANTIHYPERTENSIVE THERAPY; APPARENT MINERALOCORTICOID EXCESS SYNDROME; ARTICLE; BICARBONATE BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; CASE REPORT; CHILDHOOD DISEASE; CODON; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DNA DETERMINATION; FAILURE TO THRIVE; FOLLOW UP; GENE DELETION; GENE MUTATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPOKALEMIC ALKALOSIS; KIDNEY GRAFT; LOW BIRTH WEIGHT; MALE; MEDICAL DOCUMENTATION; PLASMA RENIN ACTIVITY; POLYDIPSIA; POLYURIA; POTASSIUM BLOOD LEVEL; REMISSION; SYSTOLIC BLOOD PRESSURE; BLOOD; CHILD; COMPLICATION; KIDNEY TRANSPLANTATION;

ADULT; CHILD; ELECTROLYTES; HUMANS; HYPERTENSION; KIDNEY TRANSPLANTATION; MINERALOCORTICOID EXCESS SYNDROME, APPARENT;

EID: 84893768282     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/jpem-2013-0235     Document Type: Article

References (8)

1. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S. Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 1977;44: 924-33
2. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, et al. A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757-64.
3. Obeyesekere VR, Ferrari P, Andrews RK, Wilson RC, New MI, et al. The R337C mutation generates a high Km 11 beta-hydroxysteroid dehydrogenase type II enzyme in a family with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1995;80:3381-3.
4. Wilson RC, Nimkarn S, New MI. Apparent mineralocorticoid excess. Trends Endocrinol Metab 2001;12:104-11.
5. Dave-Sharma S, Wilson RC, Harbison MD, Newfield R, Azar MR, et al. Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 1998;83:2244-54.
6. Palermo M, Shackleton CH, Mantero F, Stewart PM. Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man. Clin Endocrinol (Oxf) 1996;45:605-11.
7. Palermo M, Cossu M, Shackleton CH. Cure of apparent mineralocorticoid excess by kidney transplantation (Letter to the editor). N Engl J Med 1998;10;339:1787-8.
8. Palermo M, Delitala G, Sorba G, Cossu M, Satta R, et al. Does kidney transplantation normalise cortisol metabolism in apparent mineralocorticoid excess syndrome? J Endocrinol Invest 2000;23:457-62.